202 related articles for article (PubMed ID: 25612785)
1. Treatment of pulmonary arterial hypertension using extemporaneous formulation of sildenafil in Mexican children.
Juárez Olguín H; Camacho Reyes L; Roldan Arce A; Calderón Guzmán D
Pediatr Cardiol; 2015 Jun; 36(5):1019-23. PubMed ID: 25612785
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of sildenafil in children with pulmonary arterial hypertension.
Olguín HJ; Martínez HO; Pérez CF; Mendiola BR; Espinosa LR; Pacheco JLC; Pérez JF; Magaña IM
World J Pediatr; 2017 Dec; 13(6):588-592. PubMed ID: 28791664
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil in pediatric pulmonary arterial hypertension.
Dhariwal AK; Bavdekar SB
J Postgrad Med; 2015; 61(3):181-92. PubMed ID: 26119438
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.
Beghetti M; Rudzinski A; Zhang M
BMC Cardiovasc Disord; 2017 Jul; 17(1):177. PubMed ID: 28676038
[TBL] [Abstract][Full Text] [Related]
5. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
Hoeper MM; Ewert R; Jansa P; Sirenko Y; Skride A; Balagtas C; Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ
Circulation; 2024 Jun; 149(25):1949-1959. PubMed ID: 38752352
[TBL] [Abstract][Full Text] [Related]
7. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
9. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
McLaughlin V; Channick RN; Ghofrani HA; Lemarié JC; Naeije R; Packer M; Souza R; Tapson VF; Tolson J; Al Hiti H; Meyer G; Hoeper MM
Eur Respir J; 2015 Aug; 46(2):405-13. PubMed ID: 26113687
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension.
Vizza CD; Sastry BK; Safdar Z; Harnisch L; Gao X; Zhang M; Lamba M; Jing ZC
BMC Pulm Med; 2017 Feb; 17(1):44. PubMed ID: 28228114
[TBL] [Abstract][Full Text] [Related]
11. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.
Dardi F; Manes A; Palazzini M; Bachetti C; Mazzanti G; Rinaldi A; Albini A; Gotti E; Monti E; Bacchi Reggiani ML; Galiè N
Eur Respir J; 2015 Aug; 46(2):414-21. PubMed ID: 26022952
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil, pulmonary hypertension and bronchopulmonary dysplasia.
Herbert S; Tulloh R
Early Hum Dev; 2016 Nov; 102():21-24. PubMed ID: 27665322
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.
Trottier-Boucher MN; Lapointe A; Malo J; Fournier A; Raboisson MJ; Martin B; Moussa A
Pediatr Cardiol; 2015 Aug; 36(6):1255-60. PubMed ID: 25824807
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
[TBL] [Abstract][Full Text] [Related]
15. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety.
Tan K; Krishnamurthy MB; O'Heney JL; Paul E; Sehgal A
Eur J Pediatr; 2015 Aug; 174(8):1109-15. PubMed ID: 25796626
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
[TBL] [Abstract][Full Text] [Related]
18. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil improves renal function in patients with pulmonary arterial hypertension.
Webb DJ; Vachiery JL; Hwang LJ; Maurey JO
Br J Clin Pharmacol; 2015 Aug; 80(2):235-41. PubMed ID: 25727860
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
